Logo image of JBS

JBS NV-A (JBS) Stock Fundamental Analysis

NYSE:JBS - NL0015002J37 - Common Stock

16.4 USD
-0.13 (-0.79%)
Last: 8/28/2025, 3:51:09 PM
Fundamental Rating

4

JBS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 90 industry peers in the Food Products industry. While JBS is still in line with the averages on profitability rating, there are concerns on its financial health. JBS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

JBS had positive earnings in the past year.
JBS Yearly Net Income VS EBIT VS OCF VS FCFJBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

JBS has a better Return On Assets (5.10%) than 67.78% of its industry peers.
Looking at the Return On Equity, with a value of 25.34%, JBS belongs to the top of the industry, outperforming 95.56% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 11.18%, JBS belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
JBS had an Average Return On Invested Capital over the past 3 years of 8.84%. This is significantly below the industry average of 27.81%.
The last Return On Invested Capital (11.18%) for JBS is above the 3 year average (8.84%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.1%
ROE 25.34%
ROIC 11.18%
ROA(3y)3.8%
ROA(5y)N/A
ROE(3y)18.79%
ROE(5y)N/A
ROIC(3y)8.84%
ROIC(5y)N/A
JBS Yearly ROA, ROE, ROICJBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 20 30

1.3 Margins

JBS's Profit Margin of 2.65% is in line compared to the rest of the industry. JBS outperforms 60.00% of its industry peers.
JBS's Operating Margin of 6.03% is fine compared to the rest of the industry. JBS outperforms 62.22% of its industry peers.
JBS has a Gross Margin (14.56%) which is in line with its industry peers.
Industry RankSector Rank
OM 6.03%
PM (TTM) 2.65%
GM 14.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JBS Yearly Profit, Operating, Gross MarginsJBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 5 10 15

2

2. Health

2.1 Basic Checks

JBS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, JBS has about the same amount of shares outstanding.
The debt/assets ratio for JBS is higher compared to a year ago.
JBS Yearly Shares OutstandingJBS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 200M 400M 600M 800M 1B
JBS Yearly Total Debt VS Total AssetsJBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

JBS has an Altman-Z score of 2.99. This is not the best score and indicates that JBS is in the grey zone with still only limited risk for bankruptcy at the moment.
JBS has a better Altman-Z score (2.99) than 64.44% of its industry peers.
JBS has a Debt/Equity ratio of 2.39. This is a high value indicating a heavy dependency on external financing.
JBS has a Debt to Equity ratio of 2.39. This is amonst the worse of the industry: JBS underperforms 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.39
Debt/FCF N/A
Altman-Z 2.99
ROIC/WACC2.2
WACC5.08%
JBS Yearly LT Debt VS Equity VS FCFJBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.54 indicates that JBS should not have too much problems paying its short term obligations.
JBS has a Current ratio of 1.54. This is comparable to the rest of the industry: JBS outperforms 54.44% of its industry peers.
JBS has a Quick Ratio of 1.54. This is a bad value and indicates that JBS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.76, JBS is doing worse than 61.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.76
JBS Yearly Current Assets VS Current LiabilitesJBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

JBS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 988.51%, which is quite impressive.
The Revenue has been growing slightly by 5.85% in the past year.
EPS 1Y (TTM)988.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)5.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, JBS will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.49% on average per year.
Based on estimates for the next years, JBS will show a small growth in Revenue. The Revenue will grow by 5.85% on average per year.
EPS Next Y22.46%
EPS Next 2Y-0.46%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue Next Year10.09%
Revenue Next 2Y6.32%
Revenue Next 3Y5.85%
Revenue Next 5YN/A

3.3 Evolution

JBS Yearly Revenue VS EstimatesJBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
JBS Yearly EPS VS EstimatesJBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

JBS is valuated reasonably with a Price/Earnings ratio of 8.54.
Based on the Price/Earnings ratio, JBS is valued cheaper than 87.78% of the companies in the same industry.
JBS is valuated cheaply when we compare the Price/Earnings ratio to 27.14, which is the current average of the S&P500 Index.
JBS is valuated reasonably with a Price/Forward Earnings ratio of 10.39.
88.89% of the companies in the same industry are more expensive than JBS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.80. JBS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.54
Fwd PE 10.39
JBS Price Earnings VS Forward Price EarningsJBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

JBS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. JBS is cheaper than 86.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.6
JBS Per share dataJBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y-0.46%
EPS Next 3Y8.49%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 13.07%, JBS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.61, JBS pays a better dividend. On top of this JBS pays more dividend than 97.78% of the companies listed in the same industry.
JBS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 13.07%

5.2 History

JBS does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DPN/A
EPS Next 2Y-0.46%
EPS Next 3Y8.49%
JBS Yearly Income VS Free CF VS DividendJBS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 0 1B 2B

JBS NV-A

NYSE:JBS (8/28/2025, 3:51:09 PM)

16.4

-0.13 (-0.79%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13
Inst Owners0.35%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.35B
Analysts83.08
Price Target21.35 (30.18%)
Short Float %2.32%
Short Ratio5.77
Dividend
Industry RankSector Rank
Dividend Yield 13.07%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.04%
PT rev (3m)N/A
EPS NQ rev (1m)3.38%
EPS NQ rev (3m)N/A
EPS NY rev (1m)8.16%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.54
Fwd PE 10.39
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 1.59
P/tB 19.84
EV/EBITDA 4.6
EPS(TTM)1.92
EY11.71%
EPS(NY)1.58
Fwd EY9.63%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS98.77
BVpS10.34
TBVpS0.83
PEG (NY)0.38
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.1%
ROE 25.34%
ROCE 15.41%
ROIC 11.18%
ROICexc 12.19%
ROICexgc 16.66%
OM 6.03%
PM (TTM) 2.65%
GM 14.56%
FCFM N/A
ROA(3y)3.8%
ROA(5y)N/A
ROE(3y)18.79%
ROE(5y)N/A
ROIC(3y)8.84%
ROIC(5y)N/A
ROICexc(3y)10.32%
ROICexc(5y)N/A
ROICexgc(3y)14.74%
ROICexgc(5y)N/A
ROCE(3y)12.18%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity 2.39
Debt/FCF N/A
Debt/EBITDA 2.86
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 0.76
Altman-Z 2.99
F-ScoreN/A
WACC5.08%
ROIC/WACC2.2
Cap/Depr(3y)84.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)988.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y22.46%
EPS Next 2Y-0.46%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue 1Y (TTM)5.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year10.09%
Revenue Next 2Y6.32%
Revenue Next 3Y5.85%
Revenue Next 5YN/A
EBIT growth 1Y284.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.87%
EBIT Next 3Y14.06%
EBIT Next 5YN/A
FCF growth 1Y215.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.8%
OCF growth 3YN/A
OCF growth 5YN/A